Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
+$810M |
| 2 |
Intuitive Surgical
ISRG
|
+$705M |
| 3 |
S&P Global
SPGI
|
+$439M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$361M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$253M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
FedEx
FDX
|
+$587M |
| 3 |
Monster Beverage
MNST
|
+$395M |
| 4 |
McDonald's
MCD
|
+$387M |
| 5 |
Booking.com
BKNG
|
+$380M |
Sector Composition
| 1 | Technology | 22.3% |
| 2 | Consumer Discretionary | 16.25% |
| 3 | Healthcare | 15.51% |
| 4 | Financials | 12.99% |
| 5 | Communication Services | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Republic Services
RSG
$71.3B
| $3.82M | ﹤0.01% |
+52,515
| New | +$3.82M |
|
502
Inspire Medical Systems
INSP
$2.33B
| $3.79M | ﹤0.01% |
89,980
+674
| +0.8% | +$28.4K |
|
503
Eventbrite
EB
$261M
| $3.73M | ﹤0.01% |
+98,115
| New | +$3.73M |
|
504
Protagonist Therapeutics
PTGX
$3.59B
| $3.6M | ﹤0.01% |
+349,697
| New | +$3.6M |
|
|
AUTL
505
Autolus Therapeutics
AUTL
$367M
| $3.6M | ﹤0.01% |
119,190
+947
| +0.8% | +$28.6K |
|
|
SBT
506
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $3.22M | ﹤0.01% |
284,969
| – | – |
|
507
RenaissanceRe
RNR
$11.2B
| $3.16M | ﹤0.01% |
23,659
| – | – |
|
508
SPDR S&P Metals & Mining ETF
XME
$2.37B
| $3.13M | ﹤0.01% |
91,638
-30,069
| -25% | -$1.03M |
|
509
Arbutus Biopharma
ABUS
$886M
| $2.55M | ﹤0.01% |
+269,699
| New | +$2.55M |
|
510
HCA Healthcare
HCA
$92.3B
| $2.53M | ﹤0.01% |
18,202
-3,541
| -16% | -$493K |
|
511
Fortinet
FTNT
$60.9B
| $2.41M | ﹤0.01% |
130,395
-1,194,910
| -90% | -$22M |
|
|
AMR
512
DELISTED
Alta Mesa Resources, Inc. Class A Common Stock
AMR
| $2.39M | ﹤0.01% |
572,359
-55,463
| -9% | -$232K |
|
513
VF Corp
VFC
$5.85B
| $2.28M | ﹤0.01% |
25,909
-3,255
| -11% | -$286K |
|
514
LyondellBasell Industries
LYB
$17.5B
| $2.27M | ﹤0.01% |
22,121
-3,570
| -14% | -$366K |
|
515
Sutro Biopharma
STRO
$77.2M
| $2.25M | ﹤0.01% |
+150,000
| New | +$2.25M |
|
|
FDC
516
DELISTED
First Data Corporation
FDC
| $2.18M | ﹤0.01% |
88,979
+34,096
| +62% | +$834K |
|
|
DFS
517
DELISTED
Discover Financial Services
DFS
| $2.16M | ﹤0.01% |
28,191
-2,245
| -7% | -$172K |
|
518
RBC Bearings
RBC
$11.9B
| $2.15M | ﹤0.01% |
14,317
-182
| -1% | -$27.4K |
|
|
GWB
519
DELISTED
Great Western Bancorp, Inc.
GWB
| $2.14M | ﹤0.01% |
+50,677
| New | +$2.14M |
|
520
FTI Consulting
FCN
$5.23B
| $2.06M | ﹤0.01% |
28,202
-5,772
| -17% | -$422K |
|
521
Kellanova
K
$27.5B
| $2.04M | ﹤0.01% |
+30,960
| New | +$2.04M |
|
522
Omnicom Group
OMC
$14.7B
| $1.99M | ﹤0.01% |
+29,270
| New | +$1.99M |
|
523
Motorola Solutions
MSI
$80.3B
| $1.99M | ﹤0.01% |
+15,276
| New | +$1.99M |
|
524
Columbia Banking Systems
COLB
$7.84B
| $1.95M | ﹤0.01% |
50,358
-638
| -1% | -$24.7K |
|
525
MakeMyTrip
MMYT
$9.1B
| $1.94M | ﹤0.01% |
70,713
+686
| +1% | +$18.8K |
|